Stryker Corporation (SYK) Tax Rate: 28.09%
Is Stryker Corporation’s tax rate high or low?
Stryker Corporation's tax rate of 28.09% is 70% above its 5-year average of 16.51%, near the high end of its 5-year range (12.11%–28.09%).
32.56% above its 12-month average of 21.19%.
SYK Tax Rate Chart
SYK Average Tax Rate Chart
SYK Current vs Average Tax Rate Chart
SYK Tax Rate Metrics
TAX RATE
28.09%
TAX RATE AVG TTM
21.19%
TAX RATE AVG 3Y
17.08%
TAX RATE AVG 5Y
16.51%
TAX RATE AVG 10Y
13.53%
TAX RATE AVG 15Y
18.20%
TAX RATE AVG 20Y
21.35%
CURRENT VS TTM AVG
+32.56%
CURRENT VS 3Y AVG
+64.46%
CURRENT VS 5Y AVG
+70.12%
CURRENT VS 10Y AVG
+107.60%
CURRENT VS 15Y AVG
+54.36%
CURRENT VS 20Y AVG
+31.58%
Stryker Corporation Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Stryker Corporation Tax Rate FAQ
- What is the tax rate for Stryker Corporation (SYK)?
- The tax rate for SYK stock is 28.09%.
- Is Stryker Corporation's tax rate high or low?
- Stryker Corporation's tax rate of 28.09% is 70% above its 5-year average of 16.51%, near the high end of its 5-year range (12.11%–28.09%).
- What is the TTM average tax rate for Stryker Corporation (SYK)?
- The TTM average tax rate for SYK stock is 21.19%.
- What is the 3Y average tax rate for Stryker Corporation (SYK)?
- The 3Y average tax rate for SYK stock is 17.08%.
- What is the 5Y average tax rate for Stryker Corporation (SYK)?
- The 5Y average tax rate for SYK stock is 16.51%.
- What is the 10Y average tax rate for Stryker Corporation (SYK)?
- The 10Y average tax rate for SYK stock is 13.53%.
- What is the 15Y average tax rate for Stryker Corporation (SYK)?
- The 15Y average tax rate for SYK stock is 18.20%.
- What is the 20Y average tax rate for Stryker Corporation (SYK)?
- The 20Y average tax rate for SYK stock is 21.35%.
Stryker Corporation Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2025-12-31 | 28.09% |
| 2024-12-31 | 14.29% |
| 2023-12-31 | 13.83% |
| 2022-12-31 | 12.11% |
| 2021-12-31 | 12.58% |
| 2020-12-31 | 18.17% |
| 2019-12-31 | 18.70% |
| 2018-12-31 | -50.81% |
| 2017-12-31 | 50.56% |
| 2016-12-31 | 14.26% |
| 2015-12-31 | 17.06% |
| 2014-12-31 | 55.60% |
| 2013-12-31 | 17.00% |
| 2012-12-31 | 23.87% |
| 2011-12-31 | 20.23% |
| 2010-12-31 | 26.38% |
| 2009-12-31 | 31.81% |
| 2008-12-31 | 27.36% |
| 2007-12-31 | 27.98% |
| 2006-12-31 | 29.54% |
| 2005-12-31 | 31.00% |
| 2004-12-31 | 35.05% |
| 2003-12-31 | 30.50% |
| 2002-12-31 | 31.79% |
| 2001-12-31 | 33.00% |
| 2000-12-31 | 34.01% |
| 1999-12-31 | 34.90% |
| 1998-12-31 | 34.00% |
| 1997-12-31 | 35.84% |
| 1996-12-31 | 37.12% |
Related Metrics
About Stryker Corporation
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kevin A. Lobo